40.02
-0.37%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Relx PLC ADR
Its shares trade under the ticker RELX. It has been listed since 7 October 1994. In the fiscal year to 31 December 2025, it reported revenue of $9.38bn and net income of $2.02bn. At that date it held total assets of $14.73bn and shareholders' equity of $2.36bn.
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Industrials
- Industry
- Professional Services
- Listed since
- 7 Oct 1994
- Employees
- 37,000
- Website
- relx.com ↗
- Head office
- 1-3 STRAND, LONDON, X0, WC2N 5JR
- Incorporated in
- X0
- Classification
- Services-Business Services, NEC
- Filer status
- Large accelerated filer
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Relx PLC's Risk segment provides analytics for healthcare risk prediction and commercial products.
- Relx PLC's Scientific, Technical & Medical segment offers comprehensive healthcare data sets.
- Relx PLC's Legal segment delivers legal and regulatory information analytics tools.
Weaknesses
- Relx PLC's Exhibitions segment relies on in-person events which face digital competition.
- Relx PLC's headquarters in London may face geopolitical challenges in Europe.
- Relx PLC's 37000 employees require significant operational management costs.
Opportunities
- Relx PLC can expand its Risk segment into emerging markets like Asia-Pacific.
- Relx PLC's Scientific segment can leverage AI for advanced healthcare analytics.
- Relx PLC's Legal segment can integrate with global regulatory frameworks.
Threats
- Relx PLC's Risk segment faces competition from new AI-driven analytics firms.
- Relx PLC's Exhibitions segment is vulnerable to pandemic-related event cancellations.
- Relx PLC's Legal segment must adapt to evolving global data privacy laws.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.